Litcius/Paper detail

Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1

John A. McCulloch, Diwakar Davar, Richard R. Rodrigues, Jonathan H. Badger, Jennifer R. Fang, Alicia M. Cole, Ascharya K. Balaji, Marie Vétizou, Stephanie Prescott, Miriam R. Fernandes, Raquel Costa, Wuxing Yuan, Rosalba Salcedo, Erol Bahadiroglu, Soumen Roy, Richelle DeBlasio, Robert M. Morrison, Joë-Marc Chauvin, Quanquan Ding, Bochra Zidi, Ava Lowin, Saranya Chakka, Wentao Gao, Ornella Pagliano, S. Ernst, Amy Rose, Nolan K. Newman, Andrey Morgun, Hassane M. Zarour, Giorgio Trinchieri, Amiran Dzutsev

2022Nature Medicine436 citationsDOIOpen Access PDF

Topics & Concepts

Immune systemAdverse effectMelanomaMedicineImmunologyInternal medicineCancer researchGut microbiota and healthCancer Immunotherapy and BiomarkersDermatology and Skin Diseases
Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1 | Litcius